Urinary symptom flare following I-125 prostate brachytherapy-Reference-Cited by-同舟云学术

Urinary symptom flare following I-125 prostate brachytherapy

Published:2003-07 Issue:4 Volume:56 Page:1085-1092
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cesaretti Jamie A,Stone Nelson N,Stock Richard G

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference40 articles.

1. Treatments for prostate cancer in older men;Bubolz;Urology,2001

2. Mettlin CJ, Murphy GP, Rosenthal DS, et al. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1988;83:1679–1684

3. Opportunities in U.S. Prostate Disease Diagnosis and Management Markets—Prostate Cancer Management. Newport Beach, CA: Medical Data International; August 1999

4. 10-year biochemical (prostate-specific antigen) control of prostate cancer with I-125 brachytherapy;Grimm;Int J Radiat Oncol Biol Phys,2001

5. Transperineal iodine-125 implantation for treatment of clinically localized prostate cancer. 5-year tumor control and morbidity;Storey;Int J Radiat Oncol Biol,1999

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09

2. Duration of α-1 adrenergic antagonist administration after low-dose-rate brachytherapy for prostate cancer;Japanese Journal of Clinical Oncology;2024-08-28

3. Evaluation of functional and oncological outcomes of localized prostate cancer after different minimally invasive therapeutic methods: A single center experience;Urologia Journal;2024-01-21

4. BRD4 Inhibition as a Strategy to Prolong the Response to Standard of Care in Estrogen Receptor-Positive Breast Cancer;Cancers;2023-08-11

5. Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy;Cancers;2023-08-10